Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited Share · INE268B01013 (XBOM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Krebs Biochemicals & Industries Limited
No Price
Closing Price XBOM 30.04.2026: 60,12 INR
30.04.2026 09:58
Current Prices from Krebs Biochemicals & Industries Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
KREBSBIO.NS
INR
30.04.2026 09:58
59,70 INR
-
XBOM: MSE
MSE
KREBSBIO.BO
INR
30.04.2026 04:30
60,12 INR
-
Share Float & Liquidity
Free Float 18,86 %
Shares Float 4,07 M
Shares Outstanding 21,56 M
Company Profile for Krebs Biochemicals & Industries Limited Share
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad, India.

Company Data

Name Krebs Biochemicals & Industries Limited
Company Krebs Biochemicals & Industries Limited
Website https://krebsbiochem.com
Primary Exchange XBOM MSE
ISIN INE268B01013
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Manish Kumar Jain
Market Capitalization 1 Mrd.
Country India
Currency INR
Employees 0,2 T
Address Maas Heights, 500034 Hyderabad
IPO Date 2004-01-02
Dividends from 'Krebs Biochemicals & Industries Limited'
Ex-Date Dividend per Share
14.09.2005 3,00 INR
14.09.2005 3,00 INR
21.09.2004 8,00 INR

Stock Splits

Date Split
31.01.2019 207:200

Ticker Symbols

Name Symbol
MSE KREBSBIO.BO
NSE KREBSBIO.NS
More Shares
Investors who hold Krebs Biochemicals & Industries Limited also have the following shares in their portfolio:
ACCENTRO R.EST.ANL.20/23
ACCENTRO R.EST.ANL.20/23 Bond
ANNINGT. FDG 21/32 MTN
ANNINGT. FDG 21/32 MTN Bond